Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases

BACKGROUND: Fibrosing, non-idiopathic pulmonary fibrosis (non-IPF) interstitial lung diseases (fILDs) are a heterogeneous group of diseases characterized by a different amount of inflammation and fibrosis. Therapy is currently based on corticosteroids and/or immunomodulators. However, response to th...

Descripción completa

Detalles Bibliográficos
Autores principales: Torrisi, Sebastiano Emanuele, Kahn, Nicolas, Wälscher, Julia, Sarmand, Nilab, Polke, Markus, Lars, Kehler, Eichinger, Monika, Heussel, Claus Peter, Palmucci, Stefano, Sambataro, Francesca Maria, Sambataro, Gianluca, Sambataro, Domenico, Vancheri, Carlo, Kreuter, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852748/
https://www.ncbi.nlm.nih.gov/pubmed/31718637
http://dx.doi.org/10.1186/s12890-019-0937-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852748/
https://www.ncbi.nlm.nih.gov/pubmed/31718637
http://dx.doi.org/10.1186/s12890-019-0937-0

Ejemplares similares